VectivBio Holding AG
DelistedCIK 1836379fmd_18AR6DTE0FQ71SFPZT8JQAGHBBManufacturing · Biological Products, (No Diagnostic Substances)Template: Standard
Coverage: Jan 01, 2019 to Dec 31, 2022, 6 periods
Latest annual · FY2022
Millions- Total revenues
- 27
- Operating income
- (81)
- Net income
- (94)
- Free cash flow
- (56)
Key stats
Open AnalysisCompound annual growth
- Revenue, 3 yearsFY2019 to FY2022
- n/m
VectivBio Holding AG financials: quick answers
Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.
| Metric | FY2022 | FY2021 | Change | Source |
|---|---|---|---|---|
| Revenue | $27.3 million | $0 | 20-F 2023-04-19 · proof | |
| Operating income | -$80.5 million | -$86.7 million | 20-F 2023-04-19 · proof | |
| Net income | -$93.7 million | -$87 million | 20-F 2023-04-19 · proof | |
| Cash from operating activities | -$56.3 million | -$72.1 million | 20-F 2023-04-19 · proof | |
| Free cash flow | -$56.3 million | -$72.2 million | 20-F 2023-04-19 · proof | |
| Total assets | $252.6 million | $136.5 million | +85% | 20-F 2023-04-19 · proof |
| Total liabilities | $39.2 million | $20.5 million | +91.1% | 20-F 2023-04-19 · proof |
| Cash and cash equivalents | $221.4 million | $102.7 million | +115.6% | 20-F 2023-04-19 · proof |
- What was VectivBio Holding AG's revenue in fiscal 2022?
- VectivBio Holding AG reported revenue of $27.3 million for fiscal 2022 (the year ended Dec 31, 2022), against $0 the year before. Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What was VectivBio Holding AG's operating income in fiscal 2022?
- VectivBio Holding AG reported operating income of -$80.5 million for fiscal 2022 (the year ended Dec 31, 2022), against -$86.7 million the year before. Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What was VectivBio Holding AG's net income in fiscal 2022?
- VectivBio Holding AG reported net income of -$93.7 million for fiscal 2022 (the year ended Dec 31, 2022), against -$87 million the year before. Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What was VectivBio Holding AG's cash from operating activities in fiscal 2022?
- VectivBio Holding AG reported cash from operating activities of -$56.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$72.1 million the year before. Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What was VectivBio Holding AG's free cash flow in fiscal 2022?
- VectivBio Holding AG reported free cash flow of -$56.3 million for fiscal 2022 (the year ended Dec 31, 2022), against -$72.2 million the year before. Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What are VectivBio Holding AG's total assets?
- As of Dec 31, 2022, VectivBio Holding AG reported total assets of $252.6 million, against $136.5 million a year earlier (+85%). Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What are VectivBio Holding AG's total liabilities?
- As of Dec 31, 2022, VectivBio Holding AG reported total liabilities of $39.2 million, against $20.5 million a year earlier (+91.1%). Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
- What are VectivBio Holding AG's cash and cash equivalents?
- As of Dec 31, 2022, VectivBio Holding AG reported cash and cash equivalents of $221.4 million, against $102.7 million a year earlier (+115.6%). Source: the 20-F filed with the SEC on Apr 19, 2023. SEC
Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.
The same numbers for an agent, with proof on every value:
curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1836379&period_type=annual&limit=5"Information only, not investment advice.